Artículos por temáticas

Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson's Disease Mutations

Lee YJ, Syed K, Busquets O, Li H, Dunnack J, Bateup HS, Soldner F, Hockemeyer D, Rio DC.

bioRxiv [Preprint]. 2025 Sep 4:2024.02.28.582420. doi: 10.1101/2024.02.28.582420.

Retraction notice to "Enriched environment promotes similar neuronal and behavioral recovery in a young and aged mouse model of Parkinson's disease" [Neuroscience 172 (2011) 443-452]

Goldberg NRS, Haack AK, Meshul CK.

Neuroscience. 2025 Sep 13;583:187. doi: 10.1016/j.neuroscience.2025.03.022. Epub 2025 Apr 17.

Letter to the editor: "Letter to the editor: Immersive virtual reality for cognitive training in Parkinson's disease - Future directions and neuroimaging perspectives"

Yang H, Zhang G, Gu X, Chen J, Zhou W, Xu W.

J Neurol Sci. 2025 Sep 15;476:123637. doi: 10.1016/j.jns.2025.123637. Epub 2025 Jul 24.

Apathy in Neuropsychiatric Disorders: Clinical Characteristics, Neurobiological Mechanisms, and Therapeutic Strategies

Totuk O, Şahin S.

Behav Neurol. 2025 Sep 15;2025:3788122. doi: 10.1155/bn/3788122. eCollection 2025.

Development of LRRK2 inhibitors through computational strategies: a promising avenue for Parkinson's disease

Gong X, Tan S, Yang Y, Yu Y, Yao X, Liu H.

Drug Discov Today. 2025 Sep;30(9):104446. doi: 10.1016/j.drudis.2025.104446. Epub 2025 Aug 13.

[Micturition disorders in people aged 65 and more]

Wróbel M, Zapołoch S, Skawina I.

Med Pr. 2025 Sep 8;76(3):199-207. doi: 10.13075/mp.5893.01623. Epub 2025 Jul 14.

Amyotrophic Lateral Sclerosis Masquerading as Multiple System Atrophy with Parkinsonism and Anxiety as Initial Manifestations

Tang H, Yao J, Wang Z.

Degener Neurol Neuromuscul Dis. 2025 Sep 10;15:95-100. doi: 10.2147/DNND.S531647. eCollection 2025.

Biological and translational attributes of mitochondrial DNA copy number: Laboratory perspective to clinical relevance

Parchwani D, Singh R, Patel D.

World J Methodol. 2025 Sep 20;15(3):102709. doi: 10.5662/wjm.v15.i3.102709. eCollection 2025 Sep 20.

Dopa-responsive dystonia and young-onset parkinsonism in a patient with heterozygous mutation in SPR and PRKN treated with pallidal stimulation

García-de Soto J, Fernández-Pajarín G, García Estévez DA, Sesar Á.

Neurologia (Engl Ed). 2025 Sep;40(7):713-715. doi: 10.1016/j.nrleng.2025.07.005. Epub 2025 Jul 19.

MRI-Based Evidence of Regular Physical Activity's Impact on Brain Networks for Modifying Disease Courses in Parkinson Disease

Gonzalez-Escamilla G, Groppa S.

Neurology. 2025 Sep 9;105(5):e214059. doi: 10.1212/WNL.0000000000214059. Epub 2025 Aug 6.

Gamification-based tele-rehabilitation for physical therapy in patients with Parkinson's disease: A scoping review

Norouzi-Ghazbi S, Mirbaha S, Li Z, Andrysek J, Goldstein R, Hitzig SL.

PLoS One. 2025 Aug 29;20(8):e0326705. doi: 10.1371/journal.pone.0326705. eCollection 2025.

Precision Beyond Pills: The Era of Implantable Microchips in Controlled Drug Delivery

Saha A, Khanna A, Nair A, Butola BS, Sharma N, Sharma N.

J Biomed Mater Res B Appl Biomater. 2025 Sep;113(9):e35645. doi: 10.1002/jbm.b.35645.

Grueneberg Ganglion: An Unexplored Site for Intranasal Drug Delivery in Alzheimer's Disease

Kakoty V, Kang JH, Lee OH, Oh DH, Ko YT.

ACS Chem Neurosci. 2025 Sep 17;16(18):3425-3437. doi: 10.1021/acschemneuro.5c00376. Epub 2025 Sep 4.

Reply: Immersive virtual reality for cognitive training in Parkinson's disease - Future directions and neuroimaging perspectives

Fiorenzato E, Zabberoni S, Costa A, Antonini A, Cona G.

J Neurol Sci. 2025 Sep 15;476:123636. doi: 10.1016/j.jns.2025.123636. Epub 2025 Jul 25.

Multimodal Imaging of Blood-Brain Barrier Dysfunction in Parkinson's Disease: From Pathological Mechanisms to Therapeutic Opportunities

Lu Z, Yin H, Xiang P, Yi X, Tian X, Gong Q.

Eur J Neurosci. 2025 Sep;62(5):e70237. doi: 10.1111/ejn.70237.